Skip to main content

Table 1 Baseline characteristics of the “PR + maintenance” COPD patients

From: Efficacy of a long-term pulmonary rehabilitation maintenance program for COPD patients in a real-life setting: a 5-year cohort study

 

n = 144

Sex ratio (%males)

56.9%

Age years

66.26 (8.48)

BMI kg/m2

26.59 (5.29)

FEV1 %pred

63.18 (25.78)

FEV1/VC

52.73 (13.24)

Disease severity (GOLD)

 

 I

25.6%

 II

40.6%

 III

24.8%

 IV

9.0%

Smoking history pack-year

37.89 (25.81)

BODE Index

2.64 (1.88)

6MWD m

454.51 (97.98)

6MWD %pred

74.38 (17.07)

MRC

2.45 (1.26)

VQ11

25.53 (8.28)

Comorbidities

 Mean number of comorbidities per patient

2.26 (1.72)

 Pulmonary n (% total)

66 (45.8%)

 Cardiovascular n (% total)

86 (59.7%)

 Metabolic n (% total)

47 (32.6%)

 Neurologic n (% total)

7 (4.9%)

 Joint and muscle disorders n (% total)

16 (11.1%)

 Others n (% total)

23 (16.0%)

  1. Data are presented as means (SD). Disease severity classified according to the GOLD guidelines: stage I, mild, FEV1 > 80% of predicted normal value; stage II, moderate, FEV1 50–79%; stage III, severe, FEV1 30–49%; stage IV, very severe, FEV1 < 30%
  2. BMI body mass index, FEV1 forced expiratory volume in 1 s, VC vital capacity, 6MWD 6-min walking distance, %pred % predicted, MRC modified Medical Research Council dyspnea score, VQ11 short health-related quality of life questionnaire